eXoZymes, Inc. (EXOZ)
NCM · Healthcare · Biotechnology
$7.10
-7.79%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$64.7M
Shares Outstanding
9.1M
Exchange
NCM
Currency
USD
About eXoZymes, Inc.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.5M | -2.5M | -2.7M | -2.4M |
| Net Income | -2.4M | -2.3M | -2.7M | -2.4M |
| Diluted EPS | $-0.28 | $-0.27 | $nan | $-0.28 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -1.3M | -1.8M | -5.9M | -9.7M |
| Net Income | -1.4M | -2.0M | -5.9M | -9.2M |
| Diluted EPS | $-0.17 | $-0.25 | $-0.89 | $-1.09 |